J, N., MÁ, G., F, M., M, D., M, R., M, A., . . . S, C. (2026). Prevalence and clinical significance of anti-NOR90 antibodies in systemic sclerosis: Results from a multicentre cohort and systematic literature review. Autoimmunity reviews, 25(5), 104041. https://doi.org/10.1016/j.autrev.2026.104041
Chicago Style (17th ed.) CitationJ, Narváez, et al. "Prevalence and Clinical Significance of Anti-NOR90 Antibodies in Systemic Sclerosis: Results from a Multicentre Cohort and Systematic Literature Review." Autoimmunity Reviews 25, no. 5 (2026): 104041. https://doi.org/10.1016/j.autrev.2026.104041.
MLA (9th ed.) CitationJ, Narváez, et al. "Prevalence and Clinical Significance of Anti-NOR90 Antibodies in Systemic Sclerosis: Results from a Multicentre Cohort and Systematic Literature Review." Autoimmunity Reviews, vol. 25, no. 5, 2026, p. 104041, https://doi.org/10.1016/j.autrev.2026.104041.